Back
#1
23.9%
#1
6.9%
Top 76%
6.0%
Top 22%
5.4%
Top 3%
5.4%
Top 61%
4.5%
Top 1%
4.5%
Top 10%
4.2%
Top 5%
2.1%
Top 0.1%
2.1%
Top 7%
1.7%
Top 7%
1.3%
Top 8%
1.3%
Top 1%
1.2%
Top 0.1%
1.2%
Top 18%
1.0%
Top 9%
1.0%
Top 6%
0.8%
Top 28%
0.8%
Top 16%
0.8%
Top 9%
0.8%
Prognostic impact of age and MDS-associated mutations in NPM1-mutated AML
2025-11-06
hematology
Title + abstract only
View on medRxiv
Show abstract
Nucleophosmin-1 (NPM1) mutations define a major molecular subtype of acute myeloid leukemia (AML) and is generally associated with favorable prognosis. However, the impact of myelodysplasia-associated mutations (MDSm+) on patient outcomes within this subgroup remains uncertain. We retrospectively analyzed 271 NPM1-mutated AML patients from three independent cohorts (SWOG, Fred Hutch, and Beat AML) to assess the prognostic significance of MDSm+ and its interaction with age. MDSm+ occurred in 17% ...
Predicted journal destinations
1
Blood Advances
16 training papers
2
Journal of Clinical Investigation
50 training papers
3
PLOS ONE
1737 training papers
4
Nature Communications
483 training papers
5
Frontiers in Immunology
140 training papers
6
Scientific Reports
701 training papers
7
JCI Insight
63 training papers
8
eLife
262 training papers
9
Cancers
57 training papers
10
Science Advances
52 training papers
11
Proceedings of the National Academy of Sciences
100 training papers
12
The American Journal of Human Genetics
77 training papers
13
Nature Genetics
72 training papers
14
Cell
28 training papers
15
JAMA
17 training papers
16
Frontiers in Medicine
99 training papers
17
iScience
74 training papers
18
Cell Reports Medicine
49 training papers
19
JAMA Network Open
125 training papers
20
Nature Medicine
88 training papers
21
Nature
58 training papers